AKT1 and renal carcinoma: In renal cancer, overexpression of LINC00982 could inhibit cell proliferation and induce apoptosis of renal cancer cells, and also could regulate the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway [18].